- Home
- BRKRP vs CIMP Comparison
BRKRP vs CIMP Comparison
Compare BRKRP & CIMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$473.96
HOLD
Current Price
$25.11
Company Overview
Basic Information| Metric | BRKRP | CIMP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 11085 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | BRKRP | CIMP |
|---|---|---|
| Price | $473.96 | $25.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.1K | ★ 6.6K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $256.35 | $24.25 |
| 52 Week High | $474.99 | $25.64 |
Technical Indicators
Market Signals| Indicator | BRKRP | CIMP |
|---|---|---|
| Relative Strength Index (RSI) | 61.04 | 35.03 |
| Support Level | $425.25 | $24.91 |
| Resistance Level | N/A | $25.24 |
| Average True Range (ATR) | 10.39 | 0.08 |
| MACD | 1.08 | -0.05 |
| Stochastic Oscillator | 91.53 | 19.83 |
Price Performance
Historical Comparison BRKRP
CIMP
About BRKRP Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.